Roche has said it plans to UK price its latest ... based on a price of £1,470 for 28 capsules. Although Novartis also offered a commercially confidential discount for Gilenya in order to get ...

Experts explain how the best retinol serums can benefit your anti-aging skin care routine. Shop TODAY editors also share ...

Swiss Biotechnology firm Lonza, which purchased the Genentech facility in Vacaville last year, reported an income of 6.6 billion in Swiss francs (CHF) for the year 2024, which converts to about ...

Nestle's slumping share price is rattling shareholders and pension funds that have invested in the food giant, piling ...

Although Lonza posted slightly lower sales than analysts had expected in 2024, the Swiss CDMO suggested in its year-end report that it's in a stronger position going into 2025 thanks to improved ...

The success of the CDMO business was offset by the lower-than-planned Capsules and Health Ingredients ... California site from Roche, and a core EBITDA margin approaching 30%.

For 2025, Lonza expects strong performance in its CDMO business with CER sales growth approaching 20% and CORE EBITDA margin approaching 30%. Excluding Vacaville, which is expected to contribute ...

Three grams were supplied via capsules, and the remaining three grams were provided ... Plasma levels of TSH, T3, free T4, and TBII were measured by an automated analyzer (Cobas 6000; Roche ...

Roche (RHHBY) announced that the Food and Drug Administration has approved a New Drug Application for an Evrysdi tablet for people living with ...

Over the past nine years, patients with spinal muscular atrophy have seen the number of FDA-approved treatment options for ...

The FDA on Wednesday approved the industry’s first-ever tablet treatment for spinal muscular atrophy— Roche ’s SMN2 splicing ...